Maravai Lifesciences Holdings (MRVI) Deferred Taxes (2020 - 2024)
Maravai Lifesciences Holdings (MRVI) posted quarterly Deferred Taxes of $11000.0 for Q4 2024, down 100.0% year-over-year from $764.8 million in Q1 2024, and down 100.0% quarter-over-quarter from $764.8 million in Q4 2023.
Maravai Lifesciences Holdings (MRVI) Deferred Taxes (2020 - 2024) Analysis & Trends
Maravai Lifesciences Holdings' Deferred Taxes history runs 5 years deep, the most recent figure standing at $11000.0 for Q4 2024.
- In Q4 2024, Deferred Taxes fell 100.0% year-over-year to $11000.0; the TTM figure through Dec 2024 stood at $11000.0 (down 100.0% YoY), while the FY2025 annual figure was -$20000.0, down 281.82% from the prior year.
- Deferred Taxes for Q4 2024 stood at $11000.0, down from $764.8 million in the prior quarter.
- The five-year high for Deferred Taxes was $764.8 million in Q4 2023, with the low at -$5.5 million in Q3 2023.
- The 5-year median for Deferred Taxes is $6.7 million (2021), against an average of $52.4 million.
- The sharpest annual moves came in 2021 and 2023: Deferred Taxes jumped 1122800.0% in 2021, then slumped 159.91% in 2023.
- Maravai Lifesciences Holdings' Deferred Taxes stood at -$4.2 million in 2020, then jumped by 516.95% to $17.5 million in 2021, then tumbled by 59.86% to $7.0 million in 2022, then surged by 10807.86% to $764.8 million in 2023, then tumbled by 100.0% to $11000.0 in 2024.
- Business Quant data shows MRVI's Deferred Taxes at $11000.0 in Q4 2024, $764.8 million in Q4 2023, and -$5.5 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 764.75 Mn |
| Sep 30, 2023 | -5.53 Mn |
| Jun 30, 2023 | -2.76 Mn |
| Mar 31, 2023 | -1.52 Mn |
| Dec 31, 2022 | 7.01 Mn |
| Sep 30, 2022 | 9.23 Mn |
| Jun 30, 2022 | 12.86 Mn |
| Mar 31, 2022 | 13.22 Mn |
| Dec 31, 2021 | 17.47 Mn |
| Sep 30, 2021 | 11.23 Mn |
| Jun 30, 2021 | 6.45 Mn |
| Mar 31, 2021 | 11.76 Mn |
| Dec 31, 2020 | -4.19 Mn |
| Sep 30, 2020 | -1,000.00 |
| Mar 31, 2020 | -1.27 Mn |